| 1. |
俞云松.超廣譜β-內酰胺酶研究進展.中華醫學雜志, 2006, 86:641-644.
|
| 2. |
Kitchel B, Rasheed JK, Patel JB, et al.Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States:clonal expansion of multilocus sequence type 258.Antimicrob Agents Chemother, 2009, 53:3365-3370.
|
| 3. |
Wei ZQ, Du XX, Yu YS, et al.Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China.Antimicrob Agents Chemother, 2007, 51:763-765.
|
| 4. |
湯瑾, 李卿, 蔣燕群.對肺炎克雷伯菌碳青霉烯酶的研究進展.檢驗醫學, 2010, 25:63-66.
|
| 5. |
李春輝, 吳安華.醫療機構耐藥菌MDR、XDR、PDR的國際標準化定義專家建議(草案).中國感染控制雜志, 2011, 10:238-240.
|
| 6. |
Nordmann P, Cuzon G, Naas T.The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.Lancet Infect Dis, 2009, 9:228-236.
|
| 7. |
Falagas ME, Kastoris AC, Kapaskelis AM, et al.Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections:a systematic review.Lancet Infect Dis, 2010, 10:43-50.
|
| 8. |
Elemam A, Rahimian J, Mandell W.Infection with panresistant Klebsiella pneumoniae:a report of 2 cases and a brief review of the literature.Clin Infect Dis, 2009, 49:271-274.
|
| 9. |
許明, 林陳水, 付水星.替加環素的抗菌作用及藥理學性質.國外醫藥(抗生素分冊), 2006, 27:250-254.
|